Medical Device and Pharmaceutical Services in Japan

781.672.4200
Boston, MA

Committed to your success, from Concept to Approval.

Medical Devices and Pharmaceuticals Consulting Services for Japan

Japan Regulatory Affairs

Upcoming Events

  1. Regulatory Convergence

    October 1 - October 4

View All Events

GRP provides Regulatory, Clinical and Compliance services across the globe

North America
Latin America
Asia
European Union
Australia

Choose the Country

Australia
Brazil
Canada
China
European Union
India
Japan
Mexico
Singapore
South Korea
Taiwan
United States of America

Learn more about how we can assist you with Regulatory, Clinical and Compliance services in your country of interest

MEDICAL DEVICES CONSULTING

PHARMACEUTICALS CONSULTING

MARKET OVERVIEW

Japanese healthcare market is one of the most successful markets across the globe. It is established and is growing continuously . The healthcare sector in Japan is more focused toward the elderly population because the country has the highest number of geriatric population in the world. The policy to reduce the length of hospital stay and shift the treatment to home care centers is one of the major agendas of Japanese healthcare reform. The healthcare authorities in Japan provide less co-pay for the treatment of patients aged 75 years and above. Further, the government in Japan has taken initiatives to reduce device lag and accelerate the approval process, which provides an opportunity to foreign vendors to tap the market in Japan. The strong IP protection by the government in Japan for innovative products has created an opportunity for the launch of novel products in the country.

Japan Medical Device Market Size Japan Pharmaceutical Market Size
$26 billion $97 billion
Projected Growth Rate: 2.5% Projected Growth Rate: 2.5%

 

Japan Economic Indicators
GDP (PPP): $4.8 trillion
Per Capita GDP (PPP): $38,200
Real GDP Growth Rate: 0.6%
Population (millions): 127.3
Ethnic Diversity: 98.5% Japanese, 0.5% Korean, 0.4% Chinese, 0.6% other

JAPAN REGULATORY AUTHORITIES

In Japan there are two regulatory bodies that regulate medical devices and pharmaceuticals : Ministry of Health, Labor, and Welfare (MHLW) and Pharmaceutical Medical Devices Agency (PMDA).

MHLW is Japan’s primary regulatory body for creating and implementing safety standards for medical devices and drugs. Within the MHLW, the Pharmaceutical and Food Safety Bureau is in charge of pharmaceutical and medical device regulatory policy. The MHLW’s responsibilities in policies and administrative measures as it has the final judgment on products registration, approval or withdrawal from the market.

PMDA is an independent administrative agency that works with the MHLW to ensure the safety and quality of drugs and medical devices in Japan. PMDA is the “technical arm” of the MHLW and it is responsible for the :

  • Review and Approval of medical devices and pharmaceuticals
  • QMS/GLP/GCP inspection
  • Collection and analysis of Adverse Event Reports

For more information on MHLW, check the website link at: http://www.mhlw.go.jp/english/

For more information on PMDA, check the website link at: https://www.pmda.go.jp/english/

Our Services in Japan

  • Regulatory strategy
  • Foreign Manufacturer Accreditation Licensing (FMA).
  • Product classification
  • Medical Device registration
  • Pharmaceuticals registration
  • PMDA meeting organisation
  • Quality Management System registration
  • In-Country Representation in Japan ( MAH)
  • Pharmacovigilance
  • DMF registration
  • ICC (In country care taker) services
  • Clinical trials
  • Products reimbursement.
  • Distributor selection
  • Market access